» Articles » PMID: 19669160

Distribution of D1 and D5 Dopamine Receptors in the Primate and Rat Basolateral Amygdala

Overview
Specialty Neurology
Date 2009 Aug 12
PMID 19669160
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Dopamine, acting at the D1 family receptors (D1R) is critical for the functioning of the amygdala, including fear conditioning and cue-induced reinstatement of drug self administration. However, little is known about the different contributions of the two D1R subtypes, D(1) and D(5). We identified D(1)-immunoreactive patches in the primate that appear similar to the intercalated cell masses reported in the rodent; however, both receptors were present across the subdivisions of the primate amygdala including the basolateral amygdala (BLA). Using immunoelectron microscopy, we established that both receptors have widespread distributions in BLA. The D1R subtypes colocalize in dendritic spines and terminals, with D(1) predominant in spines and D(5) in terminals. Single-cell RT-PCR confirmed that individual BLA projection neurons express both D(1) and D(5) mRNA. The responses of primate BLA neurons to dopamine and D1R drugs were studied using in vitro slices. We found that responses were similar to those previously reported in rat BLA neurons and included a mixture of postsynaptic and presynaptic actions. We investigated the distribution of D1R in the rat BLA and found that there were similarities between the species, such as more prominent D(5) localization to presynaptic structures. The higher affinity of D(5) for dopamine suggests that presynaptic actions may predominate in the BLA at low levels of dopamine, while postsynaptic effects increase and dominate as dopaminergic drive increases. The results presented here suggest a complex action of dopamine on BLA circuitry that may evolve with different degrees of dopaminergic stimulation.

Citing Articles

Functional neuroanatomy of monoaminergic systems in the basolateral nuclear complex of the amygdala: Neuronal targets, receptors, and circuits.

McDonald A J Neurosci Res. 2023; 101(9):1409-1432.

PMID: 37166098 PMC: 10524224. DOI: 10.1002/jnr.25201.


Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?.

Yang P, Perlmutter J, Benzinger T, Morris J, Xu J Ageing Res Rev. 2019; 57:100994.

PMID: 31765822 PMC: 6939386. DOI: 10.1016/j.arr.2019.100994.


Kinase and Phosphatase Engagement Is Dissociated Between Memory Formation and Extinction.

Pagani M, Merlo E Front Mol Neurosci. 2019; 12:38.

PMID: 30842725 PMC: 6391346. DOI: 10.3389/fnmol.2019.00038.


Effect of long-term treatment with classical neuroleptics on NPQ/spexin, kisspeptin and POMC mRNA expression in the male rat amygdala.

Palasz A, Palka M, Filipczyk L, Menezes I, Rojczyk E, Worthington J J Neural Transm (Vienna). 2018; 125(7):1099-1105.

PMID: 29488100 PMC: 5999179. DOI: 10.1007/s00702-018-1868-2.


A comparative analysis of the physiological properties of neurons in the anterolateral bed nucleus of the stria terminalis in the Mus musculus, Rattus norvegicus, and Macaca mulatta.

Daniel S, Guo J, Rainnie D J Comp Neurol. 2017; 525(9):2235-2248.

PMID: 28295315 PMC: 5686388. DOI: 10.1002/cne.24202.


References
1.
Pickel V, Colago E, Mania I, Molosh A, Rainnie D . Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala. Neuroscience. 2006; 142(3):671-90. DOI: 10.1016/j.neuroscience.2006.06.059. View

2.
See R, Kruzich P, Grimm J . Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacology (Berl). 2001; 154(3):301-10. DOI: 10.1007/s002130000636. View

3.
Civelli O, Bunzow J, Grandy D . Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol. 1993; 33:281-307. DOI: 10.1146/annurev.pa.33.040193.001433. View

4.
Lamont E, Kokkinidis L . Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 1998; 795(1-2):128-36. DOI: 10.1016/s0006-8993(98)00281-9. View

5.
Sah P, Faber E, Lopez De Armentia M, Power J . The amygdaloid complex: anatomy and physiology. Physiol Rev. 2003; 83(3):803-34. DOI: 10.1152/physrev.00002.2003. View